Houston Methodist Hospital/Weill Cornell Medical College

Houston Methodist


Department of Pathology and Genomic
Houston Methodist Hospital
6565 Fannin Street
MS 205
Houston, TX 77030


Roger Bertholf, PhD, DABCC, FAACC
Telephone: 713-441-3294 Fax: 713-441-1565
E-mail: RLBertholf@houstonmethodist.org

Telephone: 713-441-4288
Fax: 713-441-1565
E-mail: xyi@houstonmethodist.org

Faculty and Research Interests

David Bernard, MD, PhDChemistry, hematology, informatics, management
Roger Bertholf, PhDChemistry, toxicology, endocrinology
Nicholas DiPaola, PhDHLA, Immunology
Todd N. Eagar, PhDHLA, Immunology
Christopher Leveque, MDBlood Bank, transfusion
Tara Miller, MDHematopathology
Randy Olsen, MD, PhDMicrobiology, molecular diagnostics
Jessica Thomas, MDMolecular diagnostics
Xin Yi, PhDChemistry, TDM, immunology, mass spectrometry
Arthur Zieske, MDHematology, urinalysis
Sridevi Devaraj, PhDClinical Chemistry (TCH/Baylor)
Beverly C Handy, MDClinical chemistry (MD Anderson Cancer Center)
Qing H. Meng, MD, PhDClinical chemistry (MD Anderson Cancer Center)
Anthony Okorodudu, PhDClinical chemistry (UTMB at Galveston)

Program Listing

Level(s) of training: Postdoctoral
Number of Positions available per year: 1 every two years
Duration of program: 2 years
Approximate annual salary or stipend: Commensurate with level of post-graduate training
Source of funding: Departmental/Research Grants
Current number of trainees: 1
Number of past graduates: 6
Date of ComACC accreditation: November 2011

Application Procedure


Doctoral degrees (PhD, MD, or PharmD and equivalent) at accredited institutions are required for admission into the program. Individuals with doctoral degrees in the following and other relevant life science areas are encouraged to apply: Clinical Chemistry, Chemistry, Biochemistry, Medicine, Molecular Biology, Toxicology, Pharmacology, Physiology, Genetics. Candidates should have met 30-hour minimum requirement of undergraduate and/or graduate level biochemistry or chemistry courses, which is required for ABCC certification. Previous experience in clinical chemistry is not required but strong interests in laboratory medicine and research is required.


Interested applicants should first submit a letter of interest to the program coordinator, Mona Abrego. On confirmation of training position vacancy, applicants should submit curriculum vitae, copies of credentials, undergraduate and graduate transcripts, and three letters of reference to the program coordinator. In addition, the applicants will need to complete an application form for the specific position on Methodist website. Applicants with education obtained at institutions outside the U.S. or Canada must, at their expense, have their credentials evaluated by acceptable agencies.


None; open until filled.

Program Description

One two-year fellowship slot is available every two academic years. The first year of the program is an introduction to and rotation through the various laboratories providing clinical services to the hospital and outpatient center. These laboratories include the core laboratory, diagnostic immunology, point-of-care testing, and satellite laboratories. Elective rotations in selected laboratory areas of interest will also be provided. Major equipment in these laboratories includes the Roche 8100 automated chemistry system, Abbott Architect, Sebia capillary electrophoresis system, and multiple LC/MS-MS instruments. The fellow will study proper testing procedures (specimen collection and processing), methodology, and clinical correlation of testing. Small research projects including, but not limited to, method development and clinical case study will also be assigned.

The second year will focus on management, on-call duty, and self-initiated research approved by the program director. During this time, the fellow will gradually assume greater responsibilities in the clinical service laboratories. The fellow will review and address laboratory management and patient care problems. The fellow is expected to obtain board certification in clinical chemistry by the American Board of Clinical Chemistry (ABCC) by the end of the fellowship.